Effects of AGI-1067 and Probucol After Percutaneous Coronary Interventions - Concepedia

Concepedia

Publication | Open Access

Effects of AGI-1067 and Probucol After Percutaneous Coronary Interventions

DOI Full Paper Access

179

Citations

18

References

2003

Year

Jean‐Claude Tardif, Jean Grégoire, Leonard Schwartz, Lawrence Title, Louise Laramée, François Reeves, Jacques Lespérance, Martial G. Bourassa, Philippe L. L’Allier, Mitchell Glass,

Abstract

AGI-1067 and probucol reduce restenosis after PCI. In contrast to probucol, AGI-1067 did not cause prolongation of the QTc interval and improved lumen dimensions of reference segments, suggestive of a direct effect on atherosclerosis.

References

	Year	Citations
The Effect of Cholesterol-Lowering and Antioxidant Therapy on Endothelium-Dependent Coronary Vasomotion Todd J. Anderson, Ian T. Meredith, Alan C. Yeung, New England Journal of Medicine	1995	1.1K
Probucol and Multivitamins in the Prevention of Restenosis after Coronary Angioplasty Jean‐Claude Tardif, Gilles Côté, Jacques Lespérance, New England Journal of Medicine	1997	567
Vitamin E in human low-density lipoprotein. When and how this antioxidant becomes a pro-oxidant Vincent W. Bowry, K. U. Ingold, Roland Stocker Biochemical Journal Human Low-density LipoproteinLow-density LipoproteinLipid PeroxidationHyperlipidemiaRedox Biology	1992	509
Gene Transfer and Hepatic Overexpression of the HDL Receptor SR-BI Reduces Atherosclerosis in the Cholesterol-Fed LDL Receptor–Deficient Mouse Karen Kozarsky, Mary H. Donahee, Jane M. Glick, Arteriosclerosis Thrombosis and Vascular Biology	2000	335
Effects of probucol and pravastatin on common carotid atherosclerosis in patients with asymptomatic hypercholesterolemia Yasunori Sawayama, Chie Shimizu, Naoyasu Maeda, Journal of the American College of Cardiology Asymptomatic HypercholesterolemiaMetabolic SyndromeVascular DiseaseCardiovascular DiseaseDiabetes	2002	224
Inhibition of hypercholesterolemia-induced atherosclerosis in the nonhuman primate by probucol. I. Is the extent of atherosclerosis related to resistance of LDL to oxidation? Masakiyo Sasahara, Elaine W. Raines, Alan Chait, Journal of Clinical Investigation Lipid PeroxidationHyperlipidemiaNonhuman PrimateHypercholesterolemia-induced AtherosclerosisOxidative Stress	1994	221
Effectiveness of an Antioxidant in Preventing Restenosis After Percutaneous Transluminal Coronary Angioplasty: The Probucol Angioplasty Restenosis Trial Hisashi Yokoi, Hiroyuki Daida, Yoichi Kuwabara, Journal of the American College of Cardiology Percutaneous Coronary InterventionPreventing RestenosisCardiovascular DiseaseMedicinePharmacology	1997	185
Effects of Probucol on Vascular Remodeling After Coronary Angioplasty Gilles Côté, Jean‐Claude Tardif, Jacques Lespérance, Circulation	1999	134
Transient release of lipid peroxides after coronary artery balloon angioplasty Michael J. Roberts, Thomas G. Trouton, Mazhar M. Khan, The Lancet Percutaneous Coronary InterventionCardiovascular DiseaseAngiologyTransient ReleaseMedicine	1990	129
Angioplasty increases coronary sinus F2-isoprostane formation: evidence for in vivo oxidative stress during PTCA Luigi Iuliano, Domenico Praticò, Cesare Greco, Journal of the American College of Cardiology Percutaneous Coronary InterventionCardiovascular DiseaseAtherosclerosisMedicinePhysiology	2001	113

Page 1